New butyrate pill tested alongside statins for cholesterol control
NCT ID NCT06556745
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new drug called BKR-017 in 9 adults already taking statins for high cholesterol. Researchers checked how the body handles BKR-017 and whether it builds up over a week of twice-daily dosing. The main goal was to see if it is safe and how it affects butyrate levels in the blood.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill tame high cholesterol?
- Ancient herbal mix put to the test against high cholesterol
- Cookies that could fight cholesterol: pumpkin seeds and walnuts put to the test
- Could a daily pill help kids with inherited high cholesterol?
- Free meds and tailored education may cut heart risks in Low-Income seniors
- Can a smartphone app help lower bad cholesterol?